The inhibition of canine vein graft intimal thickening using a newly developed antiplatelet agent

Journal of Cardiovascular Surgery

Volumn 38, Issue 4, 1997, Pages 359-365

  Mawatari, K ^a   Komori, K ^a   Kuma, S ^a   Okazaki, J ^a   Kawasaki, K ^a   Eguchi, D ^a   Itoh, H ^a   Onohara, T ^a   Sugimachi, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Aspirin, therapeutic use; Dogs; Hyperplasia, prevention and control; Pentanoic acids; Platelet aggregation inhibitors; Tunica intima pathology; Veins transplantation

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BROXURIDINE; SATIGREL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOTRANSPLANTATION; CELL PROLIFERATION; CONTROLLED STUDY; DOG; DRUG EFFICACY; FEMORAL ARTERY; FEMORAL VEIN; LABELING INDEX; MALE; NONHUMAN; SMOOTH MUSCLE FIBER; TIME; VEIN GRAFT;

ANIMALS; ASPIRIN; BLOOD FLOW VELOCITY; BROMODEOXYURIDINE; CELL DIVISION; DOGS; FATTY ACIDS, MONOUNSATURATED; FEMORAL ARTERY; FEMORAL VEIN; HYPERPLASIA; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TUNICA INTIMA;

EID: 0030878408     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Stephens RB, Macgaven WAL. Review of 210 autologous vein bypass operations. J Cardiovasc Surg 1980;21:143-8.
2. Gunstensen J, Smith RC, EI-Maragh N. Intimal hyperplasia in autologous veins used for arterial replacement. Can J Surg 1982;25:158-61.
3. Weisel RD, Johnston KW, Baird RJ. Comparison of conduits for leg revascularization. Surgery 1981;89:8-15.
4. Shin CS, Haten JN, Abachi IF. Effect of diminished distal blood flow on the morphologic changes in autogenous vein grafts. Surg Gynecol Obstet 1980;147:189-91.
5. Berguer R, Higgins RF, Reddy DJ. Intimal hyperplasia: an experimental study. Arch Surg 1980;115:332-5.
6. Okadome K, Yukizane T, Mii S. Correlation of long-term results of femoropopliteal autogenous vein grafts with shere stress variation. J Cardiovasc Surg 1989;30:932-5.
7. Komori K, Okadome K, Funahashi S. Correlation of long-term results of extra-anatomic bypass and flow waveform analysis. Eur J Vasc Surg 1993;7-479-82.
8. Clowes AW. The role of aspirin in enhancing arterial graft patency. J Vasc Surg 1986;3:381-8.
9. Landymore RW, Karmazyn M, MacAuley MA. Correlation between the effects of aspirin and dipyridamole on platelet function and prevention of intimal hyperplasia in autologous vein grafts. Can J Cardiol 1988;1:56-9.
10. Mark KH, Joseph RM, Steven PS. Pharmacologic modulation of intimal hyperplasia in canine vein interposition grafts.J Vasc Surg 1993;17:877-87.
11. Landymore RW, MacAuley MA, Fris J. Effect of aspirin on intimal hyperplasia and cholesterol uptake in experimental bypass grafts. Can J Cardiol 1991;7(2):87-90.
12. Landymore RW, MacAuley MA, Manku MS. The effects of low, medium and high dose aspirin on intimal proliferation in autologous vein grafts used for arterial reconstruction. Eur J Cardiothorac Surg 1991;10:100-10.
13. Fhjimori T, Harada K, Saeki T. Pharmacological properties of the novel antiplatelet aggregating agent 4-cyano-5, 5-bis(4-methoxyphenyl)-4-pentenoic acid. Arzneim-Forsch/Drug Res 1987;37:1143-8.
14. Fujimori T, Harada K, Saeki T. E5510, A novel antiplatelet drug with multiple modes of action. Cardiovasc Drug Rev 1991;9:264-84.
15. Adachi H, Fujimori T, Shoji T. Inhibitory effects of a novel antiplatelet aggregating agent, E-5510, on cyclic flow variations in electrically stimulated coronary arteries of the pig. J Cardiovasc Pharmacol 1990;16:733-41.
16. Morinaga K, Eguchi H, Miyazaki T. Development and regression of intimal thickening of arterially transplanted autologous vein grafts in dogs. J Vasc Surg 1987;5:719-30.
17. Inokuchi K, Kusaba A, Kamori M. Intraluminal velocity profile analysed from flow waveforms. Surgery 1982;92:1006-15.
18. Otsuka K, Takahara H, Okadome K. Computational simulation method of intraluminal velocity profile proved by laser Doppler velocimeter. J Surg Res 1990;49:408-12.
19. Yamamura S, Okadome K, Onohara T. Blood flow and kinetics of smooth muscle cell proliferation in canine autogonous vein grafts: In vivo BrdU incorporation.J Surg Res 1994;56:155-61.
20. McDaniel MD, Huntsman WT, Miett TO. Effect of a selective thromboxane synthase inhibitor on arterial graft patency and platelet deposition in dogs. Arch Surg 1987;122:887-92.
21. Born GVR, Cross MJ. The aggregation of blood platelet. J Physiol 1963;168:178-98.
22. Itoh H, Komori K, Funahashi S. Intimal hyperplasia of experimental autologous vein graft in hyperlipidemic rabbits with poor distal runoff. Atherosclerosis 1994;110:259-70.
23. Grantzner HG. Monoclonal antibody to 5-bromo-and 5-iododexyuridine: A new reagent for detection of DNA replication. Science 1982;218:474-90.
24. Mii S, Okadome K, Onohara T. Intimal chicking and permeability of arterial autogenous vein graft in a canine poor runoff model. Surgery 1990;108:81-9.
25. Nomoto K, Saeki T, Kogushi M. Inhibitory effects of a novel antiplatelet agent, E5510, on collagen-induced platelet-derived growth factor release and aggregation of human platelets in vitro. Jpn J Pharmacol 1993;61:7-12.
26. Nakajima T, Kitajima I, Shin Hiroshi. E5510 Antagonizes Thrombin Receptor signals by inhibiting NF-k B activation. Biochem Biophys Res Co 1994;203:1181-7.
27. Yamaguchi M, Wei du, Kenneth E. Effects of aspirin, dipiridamole, and dipyridamole, and dibutyryl cyclic adenosine monophosphate on platelet-derived growth factor A chain mRNA levels in human saphenous vein endothelial cells and smooth muscle cells. Surgery 1991;110:377-84.
28. Yukizane T, Okadome K, Eguchi H. Isotopic study of the effects of platelets on development of intimal thicking in autologous vein grafts in dogs. Br J Surg 1991;78:297-302.